further demonstrated that the expanded cells could be transduced with CAR.CD19 which both improved cytotoxicity against primary B-cell precursor acute lymphoblastic leukemia (Bcp-ALL) blasts and significantly reduced the tumor burden in mice, increasing their survival (27). Here, CD19 is linked to acute lymphoblastic leukemia.